invendo medical GmbH
NEW YORK and KISSING, Germany, 2016-12-05 11:00 CET (GLOBE NEWSWIRE) --
invendo medical GmbH, a leading developer and distributor of sterile, single-use and robotically-assisted endoscopy products in the field of gastroenterology and GI surgery, today announced it has received CE Mark for theinvendoscope™ SC200, the world’s first sterile, single-use colonoscope.
“Our revolutionary technology uniquely addresses the significant challenges associated with the cleaning and disinfecting of traditional reusable endoscopes by providing an ergonomically advanced endoscope that offers both sterility and single use,” said Timo Hercegfi, Chief Executive Officer of invendo medical. “The CE Mark is a significant accomplishment for our company, which enables us to provide endoscopists in Europe with a more advanced technology to perform colonoscopies and a system that enhances patient safety over current devices.”
As part of the newinvendoscopy™ E200 System, theinvendoscope™ SC200 is a sterile and single-use colonoscope that eliminates the main challenge of gastrointestinal endoscopy: the complex reprocessing of endoscopes and therefore patients’ risk for cross-contamination.
Current infection control guidelines require that devices such as colonoscopes only be high-level disinfected, as these devices are not able to sustain the high-temperature heat of sterilization or the long process of gas sterilization in the longer term. Though disinfection eliminates most viable microorganisms, it does not remove all of them, creating opportunities for cross-contamination among patients. In fact, more healthcare-associated infection outbreaks have been linked to contaminated endoscopes than to any other medical device.
Theinvendoscope™ SC200 is a simple, safe and effective solution to clinical and hygienic challenges, ensuring that every patient has a personal endoscope. The device is always ready for physicians to use, and this advanced technology leads endoscopy ergonomics into the 21st century.
In addition to addressing an unmet need in GI endoscopy infection control,invendoscopy™ technology is robotically-assisted and ergonomically designed to offer gastroenterologists greater control and enhance physician comfort while performing procedures.
Theinvendoscope™ SC200 also received 510(k) clearance from the U.S. Food and Drug Administration earlier this year. The company anticipates market introduction in 2017.
About invendo medical
Based in Kissing (near Munich), Germany and New York, U.S.A. invendo medical is dedicated to sterile, single-use and robotically-assisted HD endoscopy products in the field of gastroenterology and GI surgery. The company has over the last years embedded several proprietary technologies into its first product, the sterile and single-use invendoscope™ SC200, and will introduce a full suite of other sterile and single-use GI endoscopes in the future.
MEDIA CONTACT:
Amy Feldman
Lazar Partners Ltd.
212-867-1779
afeldman@lazarpartners.com
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Huhtamäki Oyj8.5.2025 07:30:00 CEST | Press release
S&P Global Ratings upgraded Huhtamaki’s long-term rating to BBB- with a stable outlook
Nykredit Realkredit A/S8.5.2025 07:30:00 CEST | Press release
Interim Reports Q1 2025 - Nykredit Realkredit Group
Scatec ASA8.5.2025 07:00:00 CEST | Press release
Scatec first quarter 2025: Strong financials and increasing growth outlook
TGS ASA8.5.2025 07:00:00 CEST | Press release
TGS VESTING UNDER THE 2022 LONG-TERM INCENTIVE PLAN
Zealand Pharma8.5.2025 07:00:00 CEST | Press release
Zealand Pharma Announces Financial Results for the First Three Months of 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom